ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Boc-L-Aspartic acid 1-tert-butyl ester
C13H23NO6
289.32 g/mol
Pharmaceutical IntermediateWarning

(3S)-4-(tert-butoxy)-3-{[(tert-butoxy)carbonyl]amino}-4-oxobutanoic acid

CAS34582-32-6EC840-509-2
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a protected derivative of aspartic acid, featuring tert-butoxycarbonyl (Boc) and tert-butyl ester protecting groups. It is commonly used as an intermediate in peptide synthesis, where selective protection of amino acid functional groups is essential to control reactivity.

Intermediate for peptide synthesisProtected amino acid building block in organic synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.77

N-Boc-L-aspartic acid

CAS13726-67-5

pharmaceutical intermediate

ReferenceSame Category

Methyl (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate

CAS345891-62-5

pharmaceutical intermediate

ReferenceSame Category

(S)-6-Oxo-2-piperidinecarboxylic acid

CAS34622-39-4

pharmaceutical intermediate

ReferenceSame Category

Benzyl N-(3-hydroxypropyl)carbamate

CAS34637-22-4

pharmaceutical intermediate

ReferenceSame Category

Formamidine acetate

CAS3473-63-0

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

(3S)-4-[(2-methylpropan-2-yl)oxy]-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid

InChIKey

RAUQRYTYJIYLTF-QMMMGPOBSA-N

SMILES

CC(C)(C)OC(=O)[C@H](CC(=O)O)NC(=O)OC(C)(C)C

Synonyms (20)
  • Boc-Asp-O-t-Butyl
  • Boc-Asp-OtBu
  • Boc-Asp-OtBu, >=97.0% (TLC)
  • Boc-L-Asp-OtBu

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→